Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Kestra Medical Technologies, Ltd. targets growth in the cardiac defibrillator market with an IPO, despite operating losses.

Dr Agarwal's Health Care's upcoming listing worries investors due to a discounted grey market premium and muted subscription.

Dr Agarwal's Health Care on Tuesday said it has raised over Rs 875.5 crore from anchor investors. The public issue has a price band of Rs 382-402 per share. The IPO is a combination of a fresh issue ...

The initial public offering (IPO) of Dr Agarwal's Health Care ... The rising demand of eye-care services and health needs, asset light model, experienced management and growth potential are ...

Image Source : PIXABAY Dr Agarwal's Health Care shares are expected to be listed on BSE and NSE on February 5, 2025. Dr Agarwal's Health Care IPO: The subscription window for the initial public ...

Swedish investment firm Nalka Invest AB’s potential listing of its medical unit Asker Healthcare Group AB could take place as soon as this quarter in a deal that could raise €500 million ($519 ...

The offer received bids for 8.29 crore shares as against 5.35 crore shares on offer. The initial public offer (IPO) of Dr. Agarwals Health Care received 8,29,80,520 bids for shares as against ...

Carnegie Investment Bank AB, Nordea Bank Abp and Citigroup Inc. are leading the IPO, Bloomberg reported previously. Representatives for Nalka, Asker and BNP declined to comment. Bloomberg News has ...

Dr. Agarwal's Health Care Ltd has launched its IPO, offering a great investment opportunity. The IPO size stands at ₹3,027.26 crore, with 75 lakh shares issued as a fresh issue and 6.78 crore shares ...

Asker IPO could be Nordic region’s biggest since 2022 Nalka may seek a valuation of €2 billion or more for Asker Swedish investment firm Nalka Invest AB ’s potential listing of its medical unit Asker ...

As companies rush to prescribe popular glucagon-like peptide-1 agonist drugs, Omada Health sees an opportunity ... in many ways an IPO is like a financing. I think sometimes people inadvertently ...